On June 28, 2023, Hemostemix Inc. closed the transaction. The company received 3,362,833 units at an issue price of CAD 0.12 per unit for gross proceeds of CAD 403,539.96 in the transaction. The company has paid finder fees to one or more advisers, dealers or finders for their assistance in the private placement including: a finder's fee payable in cash not to exceed 8% of the aggregate gross proceeds, equal to CAD 19,803.19; and issuing 165,027 finder options exercisable for a period of 24 months from the closing date of the private placement, to acquire common shares at a price of CAD 0.12 per common share.